Regal Rexnord Reports Q1 2026 Results: Sales & EPS Up, but Operating Cash Flow Significantly Declines
RRX sits 69% above its 52-week low of $124.73 on elevated volume (2.2× avg).
Summary
Regal Rexnord reported increased Q1 2026 sales and EPS, but a sharp decline in operating cash flow raises concerns despite successful debt refinancing.
Key Events · Earnings and Guidance · RRX
-
Q1 2026 Financial Performance
Net sales increased 4.3% to $1,479.1 million, with organic sales growth of 1.6%. Net income attributable to Regal Rexnord Corporation rose to $64.3 million from $57.3 million in the prior year, and diluted EPS increased to $0.96 from $0.86.
-
Significant Decline in Operating Cash Flow
Net cash provided by operating activities decreased substantially to $14.9 million for Q1 2026, down from $102.3 million in Q1 2025, primarily due to working capital changes, particularly in accounts receivable.
-
Debt Refinancing and Management
The company refinanced $1,100.0 million of 2026 Senior Notes with $850.0 million from a new 2025 Term Facility, contributing to a reduction in total long-term debt from $4,764.6 million to $4,682.6 million.
-
Ongoing Restructuring Activities
Regal Rexnord incurred $8.3 million in restructuring costs during Q1 2026 and anticipates an additional $22.9 million in charges for the remainder of 2026 as part of its cost synergy initiatives.
Analysis · RRX · Technology
Regal Rexnord's Q1 2026 earnings report reveals a mixed financial picture. While the company achieved a 4.3% increase in net sales and an 11.8% rise in net income and diluted EPS, a significant concern emerges from the cash flow statement. Operating cash flow plummeted from $102.3 million in Q1 2025 to $14.9 million in Q1 2026, primarily driven by adverse working capital changes, particularly in accounts receivable. This substantial reduction in cash generation could impact short-term liquidity and investment capacity, despite successful debt refinancing activities. Investors should monitor future cash flow trends and the impact of ongoing restructuring efforts.
At the time of this filing, RRX was trading at $211.29 on NYSE in the Technology sector, with a market capitalization of approximately $14.1B. The 52-week trading range was $124.73 to $236.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.